期刊文献+

消栓肠溶胶囊对急性脑梗死患者血清TGF-β_1和神经功能的影响 被引量:2

Influence of Xiaoshuan enteric-coated capsule on serum TGF-β_1 and neurological function in patients with acute cerebral infarction
下载PDF
导出
摘要 目的:探讨消栓肠溶胶囊对急性脑梗死血清TGF-β_1及神经功能的影响。方法:选取96例急性脑梗死患者,按随机数字表法分为观察组(49例)和对照组(47例)。两组患者均按急性脑梗死进行常规治疗;观察组在对照组治疗基础上加用消栓肠溶胶囊治疗; 2周后比较两组患者血清TGF-β_1、NIHSS及Bathel指数变化。结果:治疗前两组患者血清TGF-β_1水平、NIHSS评分及Barthel指数比较,差异无统计学意义(P> 0. 05);治疗后,两组患者TGF-β_1水平较治疗前升高,差异有统计学意义(P <0. 05),NIHSS评分降低,差异有统计学意义(P <0. 05);观察组TGF-β_1水平明显高于对照组,差异有统计学意义(P <0. 01),NIHSS评分明显低于对照组,差异有统计学意义(P <0. 01);对照组治疗后Barthel指数有所升高,和治疗前比较,差异无统计学意义(P> 0. 05),而观察组患者Barthel指数升高明显,与治疗前和对照组比较,差异有统计学意义(P <0. 01)。结论:消栓肠溶胶囊可提高急性脑梗死患者的血清TGF-β_1水平,减轻炎性反应,改善神经功能,提高患者生存质量。 Objective To evaluate the influence of Xiaoshuan enteric-coated capsule on serum TGF-β1,neurological function in patients with acute cerebral infarction.Method 96 patients with acute cerebral infarction admitted to our hospital were randomly divided into observation group(49 cases)and control group(47 cases).The two groups were treated with the routine treatment of acute cerebral infarction,and the observation group was treated with Xiaoshuan enteric-coated capsule on the basis of the control group.After 2 weeks,the changes of serum TGF-β1,NIHSS and Bathel index were compared between the two groups.Results Serum TGF-β1 level,NIHSS score and Barthel index between the two groups had no statistically significant difference before treatment before treatment(P >0.05).After treatment,the level of TGF-β1 in the two groups was higher than that before the treatment(P<0.05)and NIHSS score decreased(P<0.05).The level of TGF-β1 of observation group were significantly higher than that of control group(P<0.01),and the NIHSS score was significantly lower than that of control group(P<0.01).The Barthel index of control group rised,but there were no significant difference compared with before(P >0.05).But the Barthel index of the observation group increased significantly,which was significantly different from that before treatment and the control group(P<0.01).Conclusion Xiao Shuan enteric-coated capsule can improve serum TGF-β1 level,reduce inflammatory reaction,improve neurological function and improve the quality of life in patients with acute cerebral infarction.
作者 刘红娟 管叶明 杨玲玲 刘学春 黄海丽 汪青松 许乃银 LIU Hong-juan;GUAN Ye-ming;YANG Ling-ling
出处 《吉林医学》 CAS 2019年第2期223-225,共3页 Jilin Medical Journal
基金 2014 2015南京军区医学创新课题面上课题[项目编号:14MS039 15MS047]
关键词 消栓肠溶胶囊 脑梗死 转化生长因子 神经功能 日常生活活动能力 Xiaoshuan enteric-coated capsule Cere bral infarction Transforming growth factor Neurological function Activity of daily living
  • 相关文献

参考文献6

二级参考文献118

  • 1张瑞华,杜会山,孟繁花.软脑膜侧支循环状态对大脑中动脉梗死患者预后的影响[J].中华脑科疾病与康复杂志(电子版),2012,2(2):121-122. 被引量:2
  • 2Wahlgren N, Ahrced N, Davalos A, et al; SITS-MOST Investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITSMOST): an observational study. Lancet, 2007, 369: 275-282.
  • 3Lyden PD, ed. Thrombolytic Therapy for Acute Stroke. 2nd ed. Totowa, NJ: Hmreana Press, 2005.
  • 4Wardlaw JM, Smdercock PA, Berg: E. Throrrbolytic therapy with recoinbinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cunaflative meta-analysis. Stroke, 2003, 34: 1437-1442.
  • 5Wardlaw JM, Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev, 2003, (4): CD000213.
  • 6Shanna M, Clark H, Armour T, et al. Acute stroke: evaluation and treatment. Evid Rep Technol Assess (Sunmm), 2005, (127): 1-7.
  • 7Hill MD, Buchan AM; Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Throrrbolysis for acute ischemic stroke: results of the Canadian Altephse for Stroke Effectiveness Study. CMAJ, 20(0, 172: 1307-1312.
  • 8Chung H, Refoios Canto R, Canto RR, et al. Alteplase for the treatment of acute ischaemic stroke: NICE technology appraisal guidance. Heart, 2007, 93: 1616-1617.
  • 9Saver JL, Smith EE, Fonarow GC, et al; GWTG-stroke Steering Committee and Investigators. The "golden hour" and acute brain ischemia: presenting features and lytic therapy in > 30,000 patients ariving within 60 minutes of stroke onset. Stroke, 2010, 41: 1431-1439.
  • 10Scott PA, Xu Z, Meurer WJ, et al. Attitudes and beliefs of Michigan emergmcy physicians toward tissue plasminogen activator use in stroke: baseline survey results from the INcreasing Stroke Treatment through INteractive behavioral Change Tactic (INSTINCT) trial hospitals. Stroke, 2010, 41: 2026-2032.

共引文献1046

同被引文献38

引证文献2

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部